The role of peroxidation of mitochondrial membrane phospholipids in pancreatic β-cell failure

Current Diabetes Reviews

Volumn 8, Issue 1, 2012, Pages 69-75

  Ma, Zhongmin A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cell failure; Group VIA phospholipase A 2; Metabolic stress; Mitochondrial phospholipid peroxidation; Reactive Oxygen Species (ROS); Repair of mitochondrial membranes

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARDIOLIPIN; CYTOCHROME C; FATTY ACID; PHOSPHOLIPASE A2; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN 2;

APOPTOSIS; ARTICLE; CELL REGENERATION; ENZYME RELEASE; HUMAN; INSULIN RELEASE; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; MASS SPECTROMETRY; METABOLIC STRESS; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANES; PHOSPHOLIPIDS; REACTIVE OXYGEN SPECIES;

EID: 84855824350     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912798829232     Document Type: Article

References (101)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world--a growing challenge. N Engl J Med 2007; 356: 213-5.
2. Leahy JL. Pathogenesis of Type 2 Diabetes Mellitus. Arch Med Res 2005; 36: 197-209.
3. Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005; 115: 1431-9.
4. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116: 1802-12.
5. Doria A, Patti ME, Kahn CR. The emerging genetic architecture of type 2 diabetes. Cell Metab 2008; 8: 186-200.
6. Porte D, Jr. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 1991; 40: 166-80.
7. Prentki M, Joly E, El-Assaad W, Roduit R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 2002; 51 Suppl 3: S405-13.
8. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A. Betacell adaptation and decompensation during the progression of diabetes. Diabetes 2001; 50 Suppl 1: S154-9.
9. Zhao Z, Zhao C, Zhang XH, et al. Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine Triphosphate Synthesis. Endocrinology 2009; 150: 2569-76.
10. Zraika S, Hull RL, Udayasankar J, et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 2009; 52: 626-35.
11. Marchetti P, Lupi R, Del Guerra S, Bugliani M, Marselli L, Boggi U. The beta-cell in human type 2 diabetes. Adv Exp Med Biol 2010; 654: 501-14.
12. Leahy JL, Hirsch IB, Peterson KA, Schneider D. Targeting betacell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab 2010; 95: 4206-16.
13. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
14. Joseph JW, Koshkin V, Saleh MC, et al. Free Fatty Acid-induced {beta}-Cell Defects Are Dependent on Uncoupling Protein 2 Expression. J Biol Chem 2004; 279: 51049-56.
15. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53 Suppl 1: S119-24.
16. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-7.
17. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005; 54: S108-13.
18. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212: 167-78.
19. Friederich M, Hansell P, Palm F. Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev 2009; 5: 120-44.
20. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002; 45: 85-96.
21. Marchetti P, Del Guerra S, Marselli L, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89: 5535-41.
22. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-4.
23. Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 2005; 37: 2478-503.
24. Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008; 1: 5.
25. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and betacell dysfunction. Endocr Rev 2008; 29: 351-66.
26. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of Reactive Oxygen Species by Mitochondria: Central role of complex III. J Biol Chem 2003; 278: 36027-31.
27. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001; 414: 807-12.
28. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of mitochondria in toxic oxidative stress. Mol Interv 2005; 5: 94-111.
29. Hsu FF, Turk J. Characterization of cardiolipin as the sodiated ions by positive-ion electrospray ionization with multiple stage quadrupole ion-trap mass spectrometry. J Am Soc Mass Spectrom 2006; 17: 1146-57.
30. Hsu FF, Turk J, Rhoades ER, Russell DG, Shi Y, Groisman EA. Structural characterization of cardiolipin by tandem quadrupole and multiple-stage quadrupole ion-trap mass spectrometry with electrospray ionization. J Am Soc Mass Spectrom 2005; 16: 491-504.
31. Han X, Yang J, Cheng H, Yang K, Abendschein DR, Gross RW. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 2005; 44: 16684-94.
32. Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry 2007; 46: 6417-28.
33. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-10.
34. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science 2005; 307: 380-4.
35. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 2004; 149: 19-23.
36. Jiang X, Wang X. Cytochrome C-Mediated Apoptosis. Annu Rev Biochem 2004; 73: 87-106.
37. Kagan VE, Tyurin VA, Jiang J, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 2005; 1: 223-32.
38. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 2006; 13: 1423-33.
39. Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 2008; 65: 2493-506.
40. Klingenberg M. Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 2009; 1788: 2048-58.
41. Orrenius S, Zhivotovsky B. Cardiolipin oxidation sets cytochrome c free. Nat Chem Biol 2005; 1: 188-9.
42. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000; 39: 257-88.
43. Turk J, Wolf BA, Lefkowith JB, Stump WT, McDaniel ML. Glucose-induced phospholipid hydrolysis in isolated pancreatic islets: quantitative effects on the phospholipid content of arachidonate and other fatty acids. Biochim Biophys Acta 1986; 879: 399-409.
44. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277-88.
45. Li J, Romestaing C, Han X, et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 2010; 12: 154-65.
46. Widlansky ME, Wang J, Shenouda SM, et al. Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl Res 2010; 156: 15-25.
47. 2-Mediated Repair of Mitochondrial Membrane Peroxidation. Endocrinology 2010; 151: 3038-48.
48. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 2007; 292: C33-44.
49. Gonzalvez F, Gottlieb E. Cardiolipin: setting the beat of apoptosis. Apoptosis 2007; 12: 877-85.
50. Pope S, Land JM, Heales SJ. Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target? Biochim Biophys Acta 2008; 1777: 794-9.
51. Wiswedel I, Gardemann A, Storch A, Peter D, Schild L. Degradation of phospholipids by oxidative stress--exceptional significance of cardiolipin. Free Radic Res 2010; 44: 135-45.
52. 2 Localizes in and Protects Mitochondria during Apoptotic Induction by Staurosporine. J Biol Chem 2006; 281: 22275-88.
53. Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ. Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1994; 37: 177-81.
54. Deng S, Vatamaniuk M, Huang X, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004; 53: 624-32.
55. Matschinsky FM, Glaser B, Magnuson MA. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 1998; 47: 307-15.
56. Zhang CY, Baffy G, Perret P, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105: 745-55.
57. Polonsky KS, Semenkovich CF. The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes. Cell 2001; 105: 705-7.
58. Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM. Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor-gamma Inhibition. Diabetes 2002; 51: 2749-56.
59. Echtay KS, Roussel D, St-Pierre J, et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002; 415: 96-9.
60. Echtay KS, Murphy MP, Smith RAJ, Talbot DA, Brand MD. Superoxide Activates Mitochondrial Uncoupling Protein 2 from the Matrix Side. Studies using targeted antioxidants. J Biol Chem 2002; 277: 47129-35.
61. Krauss S, Zhang C-Y, Scorrano L, et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003; 112: 1831-42.
62. De Souza CT, Araujo EP, Stoppiglia LF, et al. Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action. FASEB J 2007; 21: 1153-63.
63. Zhang CY, Parton LE, Ye CP, et al. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity-and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab 2006; 3: 417-27.
64. Murphy MP, Echtay KS, Blaikie FH, et al. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J Biol Chem 2003; 278: 48534-45.
65. Brand MD, Esteves TC. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2005; 2: 85-93.
66. Liu W, Porter NA, Schneider C, Brash AR, Yin H. Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition. Free Radic Biol Med 2011; 50: 166-78.
67. Robertson RP. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 2006; 6: 615-9.
68. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose Toxicity in beta-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection. Diabetes 2003; 52: 581-7.
69. 2 and glutathione peroxidase is required for reduction of phospholipid hydroperoxides and provides a convenient method to determine peroxide values in membranes. J Free Radic Biol Med 1985; 1: 421-7.
70. Imai H, Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 2003; 34: 145-69.
71. 2. Prog Nucleic Acid Res Mol Biol 2001; 67: 1-33.
72. 2 superfamily and its group numbering system. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 2006; 1761: 1246-59.
73. Sevanian A Lipid damage and repair. In Oxidative Damage and Repair Davies K, Ed. New York, Pergamon Press, 1988, p. 543-9.
74. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 1985; 5: 365-90.
75. 2s and lipid peroxidation. Biochim Biophys Acta 2000; 1488: 167-81.
76. 2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart. J Lipid Res 2010; 51: 525-34.
77. 2 in the pathogenesis of Barth syndrome. Proc Natl Acad Sci U S A 2009; 106: 2337-41.
78. Sparagna GC, Lesnefsky EJ. Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol 2009; 53: 290-301.
79. Hatch GM. Cell biology of cardiac mitochondrial phospholipids. Biochem Cell Biol 2004; 82: 99-112.
80. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 1996; 12: 385-9.
81. Xu Y, Malhotra A, Ren M, Schlame M. The enzymatic function of tafazzin. J Biol Chem 2006; 281: 39217-24.
82. Neuwald AF. Barth syndrome may be due to an acyltransferase deficiency. Curr Biol 1997; 7: R465-6.
83. 2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006; 38: 752-4.
84. Malik I, Turk J, Mancuso DJ, et al. Disrupted Membrane Homeostasis and Accumulation of Ubiquitinated Proteins in a Mouse Model of Infantile Neuroaxonal Dystrophy Caused by PLA2G6 Mutations. Am J Pathol 2008; 172: 406-16.
85. Cai J, Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998; 273: 11401-4.
86. Matveyenko AV, Butler PC. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 2008; 10 Suppl 4: 23-31.
87. 2 Results in Insufficient Insulin Secretion and Impaired Glucose Tolerance. Mol Endocrinol 2005; 19: 504-15.
88. 2 Deficiency in Mice: A Model of Human Neurodegenerative Disease. J Neurosci 2008; 28: 2212-20.
89. 2 produce spermatozoa with impaired motility and have greatly reduced fertility. J Biol Chem 2004; 279: 38194-200.
90. 2 and Effects of Metabolic Stress on Glucose Homeostasis. J Biol Chem 2006; 281: 20958-73.
91. 2beta-null mice. Am J Physiol Endocrinol Metab 2008; 294: E217-29.
92. Zhang M, Mileykovskaya E, Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem 2005; 280: 29403-8.
93. Gohil VM, Hayes P, Matsuyama S, Schagger H, Schlame M, Greenberg ML. Cardiolipin biosynthesis and mitochondrial respiratory chain function are interdependent. J Biol Chem 2004; 279: 42612-8.
94. Gohil VM, Greenberg ML. Mitochondrial membrane biogenesis: phospholipids and proteins go hand in hand. J Cell Biol 2009; 184: 469-72.
95. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial Oxidative Stress: Implications for Cell Death. Annual Review of Pharmacology and Toxicology 2007; 47: 143-83.
96. Subramanian S, Kalyanaraman B, Migrino RQ. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2010; 5: 54-65.
97. Leloup C, Tourrel-Cuzin C, Magnan C, et al. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 2009; 58: 673-81.
98. Loh K, Deng H, Fukushima A, et al. Reactive oxygen species enhance insulin sensitivity. Cell Metab 2009; 10: 260-72.
99. Dhanasekaran A, Kotamraju S, Kalivendi SV, et al. Supplementation of Endothelial Cells with Mitochondria-targeted Antioxidants Inhibit Peroxide-induced Mitochondrial Iron Uptake, Oxidative Damage, and Apoptosis. J Biol Chem 2004; 279: 37575-87.
100. Petrosillo G, Moro N, Ruggiero FM, Paradies G. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med 2009; 47: 969-74.
101. Petrosillo G, Colantuono G, Moro N, et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009; 297: H1487-93.